title: The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex.
abstract: The effect of ritanserin on dopamine (DA) re-uptake and efflux was studied in rat frontal cortex synaptosomes. When compared to other 5HT2 receptor antagonists such as ketanserin and risperidone or DA D2 receptor antagonists such as haloperidol and raclopride, the effect of ritanserin proved to be more potent. Ritanserin blocked the DA transporter with a Ki of 0.18 +/- 0.06 microM, similar to cocaine (0.11 +/- 0.005 microM), while ketanserin had a Ki of 0.93 +/- 0.045; haloperidol of 2.07 +/- 0.12; risperidone of 18.01 +/- 0.62 and raclopride of 24.01 +/- 1.55. In addition, 15 min from its local application to the synaptosomes, ritanserin potently released [3]H-DA leaving only 29.6 +/- 1.6% of DA content, while ketanserin effect was equal to 46.5 +/- 0.9%; haloperidol to 70.4 +/- 2.2% and risperidone to 73.9 +/- 1.5%, all tested at the dose of 10 microM. Cocaine had no effect on DA efflux. These results suggest that ritanserin has a intrinsic dopaminergic effect which may help to explain its reported improvement on mood, cognition and negative symptoms of schizophrenia.
authors: Neuroscienze Scarl, Cagliari, Italy.
authors: S
authors: S
authors: Ruiu
authors: G
authors: G
authors: Marchese
authors: P L
authors: PL
authors: Saba
authors: G L
authors: GL
authors: Gessa
authors: L
authors: L
authors: Pani
mesh_terms: D000818:Animals; D003024:Clozapine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000493:pharmacokinetics*; D018492:Dopamine Antagonists / Q000494:pharmacology; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D011985:Receptors, Serotonin / Q000378:metabolism*; D018967:Risperidone / Q000494:pharmacology; D016713:Ritanserin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D014316:Tritium
chemical_list: D018492:Dopamine Antagonists; D018765:Dopamine Uptake Inhibitors; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D014316:Tritium; D016713:Ritanserin; D007650:Ketanserin; D003042:Cocaine; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone; D004298:Dopamine